Literature DB >> 10478715

Design engineering of a bioartificial renal tubule cell therapy device.

J Nikolovski1, E Gulari, H D Humes.   

Abstract

The use of a bioartificial renal tubule device composed of renal proximal tubule cells grown within a hollow fiber cartridge is a first step in engineering a bioartificial kidney to provide more complete replacement therapy of renal function than is available today. In this study, the feasibility of two designs for a tubule device were investigated: one with cells grown on microcarrier beads densely packed within the extracapillary space of a hollow fiber cartridge, and the other with cells grown as a confluent monolayer within the hollow fibers themselves. First, the oxygen requirements of porcine renal proximal tubule cells were determined, both attached to microcarriers and in suspension and compared to that of proximal tubule segments. The basal rate of cell respiration was found to be 2.29 +/- 0.53 nmol O2/10(6) cells/min for our cultured proximal tubule cells in suspension and no significant difference was seen with attached cells. Proximal tubule segments displayed significantly higher respiratory rates. Cells were also found to be responsive in the presence of mitochondrial inhibitors or uncouplers, and their respiratory rates remained constant, despite multiple passaging. The resultant cell oxygen consumption parameter was used in models describing oxygen concentration profiles within the two device configurations. From these models, it was found that cells within our proposed device designs could theoretically be sustained and remain viable, with respect to oxygen limitations. Finally, flow visualization studies were performed to assess fluid flow distribution and determine optimal device configuration and geometry to decrease areas of low or stagnant flow.

Entities:  

Mesh:

Year:  1999        PMID: 10478715     DOI: 10.1177/096368979900800403

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  8 in total

1.  Bioengineered Renal Cell Therapy Device for Clinical Translation.

Authors:  Christopher J Pino; Angela J Westover; Deborah A Buffington; H David Humes
Journal:  ASAIO J       Date:  2017 May/Jun       Impact factor: 2.872

Review 2.  Cell-based approaches for the treatment of systemic inflammation.

Authors:  Christopher J Pino; Alexander S Yevzlin; Kyungsoo Lee; Angela J Westover; Peter L Smith; Deborah A Buffington; H David Humes
Journal:  Nephrol Dial Transplant       Date:  2012-11-09       Impact factor: 5.992

Review 3.  Stem cell technology for the treatment of acute and chronic renal failure.

Authors:  Christopher J Pino; H David Humes
Journal:  Transl Res       Date:  2010-07-30       Impact factor: 7.012

Review 4.  Cell-based strategies for the treatment of kidney dysfunction: a review.

Authors:  Christopher J Pino; Alexander S Yevzlin; James Tumlin; H David Humes
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

Review 5.  The bioartificial kidney: current status and future promise.

Authors:  H David Humes; Deborah Buffington; Angela J Westover; Shuvo Roy; William H Fissell
Journal:  Pediatr Nephrol       Date:  2013-04-26       Impact factor: 3.714

Review 6.  The bioartificial kidney in the treatment of acute kidney injury.

Authors:  Joon Ho Song; H David Humes
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

7.  Stem cells: the next therapeutic frontier.

Authors:  H David Humes
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 8.  Repopulating Decellularized Kidney Scaffolds: An Avenue for Ex Vivo Organ Generation.

Authors:  Robert A McKee; Rebecca A Wingert
Journal:  Materials (Basel)       Date:  2016-03-11       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.